Millipore Sigma Vibrant Logo

435300 LFM-A13 - CAS 62004-35-7 - Calbiochem

A potent, cell-permeable, reversible, substrate competitive, and specific inhibitor of Bruton's Tyrosine Kinase (BTK; IC₅₀ = 17.2 µM for human BTK in vitro and IC₅₀ = 2.5 µM for recombinant BTK).

LFM-A13 - CAS 62004-35-7 - Calbiochem : FDS (Fiches de données de sécurité), certificats d’analyse (CoA) et de qualité (CoQ), dossiers, brochures et autres documents disponibles.

Synonymes: α-Cyano-β-hydroxy-β-methyl-N-(2,5-dibromophenyl)propenamide, BTK Inhibitor I, Bruton's Tyrosine Kinase Inhibitor I

Primary Target: Human Bruton's Tyrosine Kinase (BTK)
View Products on Sigmaaldrich.com
435300
Voir les Prix & la Disponibilité

Aperçu

Replacement Information

Tableau de caractéristiques principal

CAS #Empirical Formula
62004-35-7C₁₁H₈Br₂N₂O₂

Prix & Disponibilité

Référence DisponibilitéConditionnement Qté Prix Quantité
435300-5MG
Récupération des données relatives à la disponibilité...
—
Disponibilité limitée Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

      		 Ampoule plast. 5 mg
      Prix en cours de récupération
      Le prix n'a pas pu être récupéré
      La quantité minimale doit être un multiple de
      Maximum Quantity is
      À la validation de la commande Plus d'informations
      Vous avez sauvegardé ()
       
      —
      Demander le prix
      		 —
      Description
      OverviewA potent, cell-permeable, reversible, substrate competitive, and specific inhibitor of Bruton’s Tyrosine Kinase (BTK; IC50 = 17.2 µM for human BTK in vitro and IC50 = 2.5 µM for recombinant BTK). Also inhibits Polo-like kinase in an ATP-competitive manner (IC50 = 10 µM and 61 µM for Plx1 and Plk3, respectively), and displays antitumor properties. Does not affect the enzymatic activity of other protein tyrosine kinases, including EGFR, HCK, IRK JAK1, and JAK3 even at concentrations of 278 µM. Enhances the chemosensitivity of BTK-positive B-lineage leukemia cells to ceramide- and vincristine-induced apoptosis.
      Catalogue Number435300
      Brand Family Calbiochem®
      Synonymsα-Cyano-β-hydroxy-β-methyl-N-(2,5-dibromophenyl)propenamide, BTK Inhibitor I, Bruton's Tyrosine Kinase Inhibitor I
      References
      ReferencesUckun, F.M., et al. 2006. Bioorg. Med. Chem. In press.
      Mahajan, S., et al. 1999. J. Biol. Chem. 274, 9587.
      Vassilev, A., et al. 1999. J. Biol. Chem. 274, 1646.
      Product Information
      CAS number62004-35-7
      ATP CompetitiveY
      FormLight brown solid
      Hill FormulaC₁₁H₈Br₂N₂O₂
      Chemical formulaC₁₁H₈Br₂N₂O₂
      ReversibleY
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetHuman Bruton's Tyrosine Kinase (BTK)
      Primary Target IC<sub>50</sub>17.2 µM for human BTK in vitro and 2.5 µM for recombinant BTK
      Purity≥97% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      435300-5MG 04055977210293

      Documentation

      LFM-A13 - CAS 62004-35-7 - Calbiochem FDS

      Titre

      Fiche de données de sécurité des matériaux (FDS) 

      LFM-A13 - CAS 62004-35-7 - Calbiochem Certificats d'analyse

      TitreNuméro de lot
      435300

      Références bibliographiques

      Aperçu de la référence bibliographique
      Uckun, F.M., et al. 2006. Bioorg. Med. Chem. In press.
      Mahajan, S., et al. 1999. J. Biol. Chem. 274, 9587.
      Vassilev, A., et al. 1999. J. Biol. Chem. 274, 1646.

      Citations

      Titre
    • Sarah L Doyle, Caroline A Jefferies and Luke A O'Neill. (2005) Bruton's tyrosine kinase is involved in p65-mediated transactivation and phosphorylation of p65 on serine 536 during NF-B activation by LPS. Journal of Biological Chemistry 280, 23496-23501.
      		•
      Fiche technique

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision12-January-2010 RFH
      Synonymsα-Cyano-β-hydroxy-β-methyl-N-(2,5-dibromophenyl)propenamide, BTK Inhibitor I, Bruton's Tyrosine Kinase Inhibitor I
      DescriptionA potent, cell-permeable, reversible, substrate competitive, and specific inhibitor of Bruton's tyrosine kinase (BTK; IC50 = 17.2 µM for human BTK in vitro and IC50 = 2.5 µM for recombinant BTK). Also inhibits Polo-like kinase in an ATP-competitive manner (IC50 = 10 µM and 61 µM for Plx1 and Plk3, respectively), and displays antitumor properties. Does not affect the enzymatic activity of other protein tyrosine kinases, including EGFR, HCK, IRK JAK1, and JAK3 even at concentrations of 278 µM. Enhances the chemosensitivity of BTK-positive B-lineage leukemia cells to ceramide- and vincristine-induced apoptosis.
      FormLight brown solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number62004-35-7
      Chemical formulaC₁₁H₈Br₂N₂O₂
      Structure formulaStructure formula
      Purity≥97% by HPLC
      SolubilityDMSO (200 mg/ml)
      Storage Protect from light
      +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesUckun, F.M., et al. 2006. Bioorg. Med. Chem. In press.
      Mahajan, S., et al. 1999. J. Biol. Chem. 274, 9587.
      Vassilev, A., et al. 1999. J. Biol. Chem. 274, 1646.
      Citation
    • Sarah L Doyle, Caroline A Jefferies and Luke A O'Neill. (2005) Bruton's tyrosine kinase is involved in p65-mediated transactivation and phosphorylation of p65 on serine 536 during NF-B activation by LPS. Journal of Biological Chemistry 280, 23496-23501.
      		•